[ad_1]
“Sputnik … has not yet been able to obtain and may never receive approval from the EVA (European Medicines Agency),” Draghi said in Brussels.
Furthermore, according to the Italian leader, “the Chinese vaccine … turned out to be inappropriate – look at the Chilean experience.”
The Chinese Sinovac vaccine was widely used during a vaccination campaign in Chile. It is now considered that vaccinated people may need a third dose to improve immune protection against new variants of the coronavirus.
Both Sputnik V and Sinovac are currently being evaluated by the EEA for use in the EU market.
Draghi said the European Medicines Agency should be “strengthened and possibly reformed” to avoid a repeat of the recent “significant confusion” about vaccines.
He noted that the COVID-19 Vaccine Safety Authority’s assessments differed from those of the national medical services.
Draghi made the remarks at the end of a two-day meeting of EU leaders, saying that he discussed the general situation in the fight against the coronavirus pandemic.
“The pandemic is not over yet, we are not out of it yet,” said the Italian leader, noting the rapid spread of a more contagious variant of the coronavirus, Delta, in the UK.
According to an ISS report from Italy’s National Institutes of Health, the original Alpha variant remained the most common in the country in June, accounting for 74.9 percent. samples analyzed.
However, on June 21, the proportion of Delta variant coronavirus infection among the samples tested increased to 16.8 percent, according to the ISS. In May, its share was just 4.2 percent.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
